• 검색 결과가 없습니다.

Image-Guided Radiotherapy for Target Localization in Prostate Cancer with Implanted Markers

N/A
N/A
Protected

Academic year: 2022

Share "Image-Guided Radiotherapy for Target Localization in Prostate Cancer with Implanted Markers"

Copied!
3
0
0

로드 중.... (전체 텍스트 보기)

전체 글

(1)

연제발표 1: Image-Guided Radiotherapy for Target Localization in Prostate Cancer with Implanted Markers, Yelin Suh, et al

-

68

-

Image-Guided Radiotherapy for Target Localization in Prostate Cancer with Implanted Markers

Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine Yelin Suh, Sung Ho Park, Seung Do Ahn, Jong Hoon Kim, Sang-Wook Lee,

Seong Soo Shin and Eun Kyung Choi

To precisely localize target in prostate cancer, image-guided radiotherapy was performed using the ExacTrac® x-ray system (Brainlab, Germany) with implanted markers. For three prostate cancer patients, three gold markers were implanted into prostate. Orthogonal portal images were acquired every treatment and CT scans were repeated 3~5 times during the course of treatment. After correcting setup errors calculated by the system, the position of the implanted markers and the distance between them were detected in daily portal images and in CT images, and analyzed retrospectively. Deviation of the relative position of the implanted markers and the distance between them were less than 1 mm in lateral, longitudinal, and vertical direction for three patients, both in portal images and CT images. This study reveals that image-guided radiotherapy using the ExacTrac® system is useful to verify positioning errors and localize prostate target with implanted markers, reducing the planning target volume (PTV) margin as well as irradiation to rectum and bladder.

Key words: Target localization, Prostate cancer, Image-guided radiotherapy, Implanted markers

INTRODUCTION

It has been reported that higher radiation dose leads to better treatment results in prostate cancer.1) However, not only is prostate a moving organ,2) there are also critical organs very near it, such as rectum and bladder. Therefore, to deliver higher dose to a target and to spare surrounding normal tissues at the same time, localizing the target precisely is essential for prostate cancer.3,4) For high-precision treatment, image-guided radiotherapy was performed for prostate cancer, using the ExacTrac® x-ray system (Brainlab, Germany) with implanted markers.

METHODS AND MATERIALS

For three prostate cancer patients, three gold markers were implanted into prostate. Following patients’ setup with skin markings, both the ExacTrac® x-ray images and orthogonal portal images were taken every treatment. The ExacTrac® system fused these two images, calculated position shifts for correcting setup errors, and moved the couch to the planned position.

At first, position shifts for bony markers were calculated and treatment couch was moved according to them. In order to verify inter-treatment setup errors, this procedure was repeated for the implanted markers. CT scans were repeated 3~5 times dur- ing the course of treatment. After correcting setup errors, the position of the implanted markers in prostate and the distance between the markers due to their inter-treatment variations were detected in daily portal images and in CT images, and ana- lyzed retrospectively (Fig. 1, 2).

RESULTS AND DISCUSSION

The correction shifts calculated by the ExacTrac® system with bony markers and with implanted markers for three patients were shown in Table 1.

(2)

제 30회 한국의학물리학회 춘계학술대회

-

69

- Fig. 1. Verification of inter-treatment errors in portal images: position of the implanted markers in pros- tate and distance between the markers due to their inter-treatment variations were acquired.

Fig. 2. Verification of inter-treatment errors in CT images: position of the implanted markers in pros- tate and distance between the markers due to their inter-treatment variations were acquired.

Patient #1 Patient #2 Patient #3

Direction Bony markers Implanted

markers Bony markers Implanted

markers Bony markers Implanted

markers Lateral

Longitudinal Vertical

0.50 ± 0.69 -1.95 ± 0.85 0.15 ± 1.31

-0.62 ± 1.12 0.51 ± 1.27 1.49 ± 2.26

2.21 ± 0.58 -3.19 ± 0.46 3.27 ± 1.07

1.82 ± 0.75 -7.15 ± 2.65 0.07 ± 3.17

0.15 ± 1.55 -1.37 ± 1.09 -5.84 ± 2.12

-0.89 ± 1.28 -3.80 ± 2.03 -4.96 ± 3.45 Table 1. Correction shifts calculated by the ExacTrac® system with bony markers and with implanted markers for three patients (mm)

After correcting positioning errors with the implanted markers, deviation of the relative position of the implanted markers and the distance between them were less than 1 mm in lateral, longitudinal, and vertical direction for three patients, both in portal images and CT images, as shown in Fig. 3.

CONCLUSION

The motion of prostate, which has been reported up to 20 mm2), can cause geometrical uncertainties in daily localization of target volume. With the help of the ExacTrac® system, inter-treatment errors were reduced to less than 1 mm for all three patients. It means that the planning target volume (PTV) margin for prostate, which is usually 10~15 mm2), can be reduced to 3~5 mm. Tight margin makes it possible to concentrate dose on target and spare critical organs3), so that this study re- veals that image-guided radiotherapy using the ExacTrac® system is useful to localize prostate target with implanted markers.

Moreover, since the ExacTrac® system guarantees that the position of prostate is precisely verified prior to each treatment fraction, it can substitute for daily portal images in verifying setup.

(3)

연제발표 1: Image-Guided Radiotherapy for Target Localization in Prostate Cancer with Implanted Markers, Yelin Suh, et al

-

70

-

Fig. 3. Deviation of marker position and distance between markers in portal images and CT images in lateral, longitudinal, and vertical direction for three patients: (a) marker position and (b) distance between markers in por- tal images, and (c) marker position and (d) distance between markers in CT images.

REFERENCES

1. Hanks GE, Hanlon AL, Epstein B, Horwitz EM: Dose response in prostate cancer with 8~12 years’ follow-up. Int J Radiat Oncol Biol Phys 54:427-35 (2002)

2. Dawson LA, MahK, Franssen E, Morton G: Target position variability throughout prostate radiotherapy. Int J Radiat Oncol Biol Phys 42:1155-61 (1998)

3. Smitsmans MHP, Wolthaus JWH, Artignan X, et al: Automatic localization of the prostate for on-line or off-line image-guided radiotherapy. Int J Radiat Oncol Biol Phys 60:623-35 (2004)

4. Ghilezan M, Yan D, Liang J, Jaffray D, Wong J, Martinez: A Online image-guided intensity-modulated radiotherapy for prostate cancer: how much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery. Int J Radiat Oncol Biol Phys 60:1602-10 (2004)

참조

관련 문서

• 이명의 치료에 대한 매커니즘과 디지털 음향 기술에 대한 상업적으로의 급속한 발전으로 인해 치료 옵션은 증가했 지만, 선택 가이드 라인은 거의 없음.. •

12) Maestu I, Gómez-Aldaraví L, Torregrosa MD, Camps C, Llorca C, Bosch C, Gómez J, Giner V, Oltra A, Albert A. Gemcitabine and low dose carboplatin in the treatment of

Based on the diversity of RAPD profiles and specific band markers linked with specific mating type, the OPC-5 primer was selected for determination of mating type among the

Levi’s ® jeans were work pants.. Male workers wore them

The fibrin/MSC-coated 3DP PCL scaffold was implanted on a 5 × 10 mm artificial oesophageal defect in three rabbits (3DP/MSC group) and 3DP PCL-only scaffolds were implanted

Furthermore, the serum levels of CXCL10 and CXCL13 in patients with AOSD correlated with those of several inflammatory markers, and systemic scores, and the serum levels of

Purpose: The aim of the study was to identify risk and protective factors/markers for cervical cancer and cervical intraepithelial neoplasia 3 (CIN3) in Israeli Jewish women

Therefore, the aim of this study is to deter- mine whether subcutaneous temperature (ST) recorded by subcutaneously implanted thermo-logger sensors is correlated with